Trial Profile
Ciclosporin in the prevention of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Dec 2021
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Myocardial infarction; Reperfusion injury
- Focus Registrational; Therapeutic Use
- Acronyms CIRCUS
- 13 Oct 2016 Status changed from active, no longer recruiting to completed.
- 31 Aug 2015 According to NeuroVive Pharmaceuticals media release, results will be presented at the European cardiology meeting.
- 02 Jun 2015 Trial design published in the American heart journal.